With the dust now settled around the pharmacy contract announcement for 2026/27 – and a new health secretary and health ministers just in post as well – we’ve been taking time to again review the changes to the contract.
What are the longer-term trends for community pharmacies?
The release of the 2026/27 Community Pharmacy Contractual Framework (CPCF) at the end of May brought yet another round of changes to how community pharmacies in England are funded and expected to deliver care.
While the headline figures might have provided some relief to overstretched pharmacies, the broader message is clear – the sector is continuing its shift towards clinical services, operational efficiency and measurable performance.
Understanding what this means ahead is critical.
From our perspective at RWA Pharmacy, success under the new contract will depend on how well pharmacies can align their operations with these evolving expectations. Transparency will be key.
CPCF 2026/27 at a glance
The most visible update to the contract was the £3.636 billion total funding envelope, representing a £340 million increase for 2026/27. Importantly, the Pharmacy First budget was integrated into the CPCF, giving greater certainty around income linked to clinical services. There were also targeted financial adjustments with the Single Activity Fee increased slightly to £1.52 per item, and the medicines margin increased to £1.1 billion, with historic over-delivery written off.
While these changes support short-term stability, they don’t fundamentally change the economics of dispensing. Pharmacies must still manage rising costs and increasing prescription volumes within relatively tight margins.
From April payment data we saw an average of 18p in average item value (AIV) movement. This will account for some reflection of the dispensing fee change of 6p but it was also encouraging to the see the NIC increasing by an average of 12p. For an average pharmacy dispensing 9,000 items that is a starting increase of £1,600 per month.
A continued shift towards clinical care
The 2026/27 contract reinforces the expanding role of community pharmacy in primary care.
Pharmacy First remains central, reflecting growing patient demand for accessible care outside of GP settings. More significantly, all pharmacists from autumn will be independent prescribers, enabling pharmacists to assess and treat patients directly within defined pathways.
This development strengthens the clinical position of pharmacies, but it also brings new responsibilities. Pharmacies will need to manage:
- Service delivery alongside dispensing
- Increased clinical governance requirements
- Workforce training and capacity.
The opportunity is clear – but so is the complexity.
Managing growing operational pressure
Alongside these changes, pharmacies are still navigating a high-pressure environment. The contract includes some efforts to reduce administrative burden, but day-to-day operations remain demanding.
Pharmacies must balance:
- Dispensing at scale
- Delivering more services
- Maintaining profitability
- Meeting quality requirements.
For many independent businesses, this is no longer just a question of workload – it is about where to focus time and resource to remain sustainable.
Why visibility and data matter more than ever
One of the biggest shifts within the CPCF is the growing emphasis on measurable activity and performance. Income is increasingly tied to accurate claims, service thresholds and operational efficiency. This makes real-time visibility across the business essential.
Supporting independent pharmacies through change
At RWA Pharmacy, we consistently see that pharmacies have access to large volumes of data, but limited capacity to act on it.
Independent pharmacies are increasingly expected to operate with the same level of oversight as larger groups, often without the same internal support.
RWA tools such as Independents+ Insights have been developed to bridge that gap, providing automated reporting and clear, usable insights across the business. This allows teams to spend less time on manual reporting and more time focusing on patients and services – which is essential in a contract environment where both are under pressure.
The solutions are designed to simplify this. By bringing together over 40 of the pharmacy data sets such as dispensing data, service performance, NHS payments and public datasets and many other digital technologies into a single view, we help pharmacies:
- make more informed daily decisions
- identify missed income opportunities
- track performance against CPCF thresholds
- reduce stock inefficiencies and waste
- clearly forecast margin trends & risks
- support a managed cashflow.
Final thoughts
Looking forward, the CPCF 2026/27 should be seen as part of a wider transition rather than a final solution. Community pharmacies are being positioned as more integrated, clinically focused providers within the NHS. However, delivering on that role requires strong operational foundations.
From our perspective at RWA Pharmacy, the pharmacies that will succeed are those that combine:
- efficient dispensing operations
- clear financial visibility
- structured service delivery
- data-driven decision-making.
The contract sets the direction, but it is how pharmacies respond that will determine long-term sustainability.
